Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Brands Inc (NQ: TLRY )

1.320 +0.030 (+2.33%)
Streaming Delayed Price Updated: 1:25 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,739,335
Open 1.300
Bid (Size) 1.310 (909)
Ask (Size) 1.320 (470)
Prev. Close 1.290
Today's Range 1.280 - 1.360
52wk Range 1.280 - 2.970
Shares Outstanding 730,289,573
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide
Indulge in Premium Chocolate Edibles, Cannabis-Infused Drinks, New Pre-Rolls, and Top-Quality Flower - the Perfect Selection for Cannabis Connoisseurs this Festive Season! 
From Tilray Brands, Inc.
Via GlobeNewswire

Performance

YTD
-40.54%
-40.54%
1 Month
-16.46%
-16.46%
3 Month
-30.16%
-30.16%
6 Month
-29.03%
-29.03%
1 Year
-25.84%
-25.84%

More News

Read More
How Is The Market Feeling About Tilray Brands?
Via Benzinga
Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide
From Tilray Brands, Inc.
Via GlobeNewswire
Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
These 2 Marijuana Stocks Could Surge Under Trump's Second Term
Via The Motley Fool
Topics Cannabis Government
Exposures Cannabis Political
Beverages, Alcohol and Tobacco Stocks Q3 Recap: Benchmarking Tilray Brands (NASDAQ:TLRY)
Via StockStory
Topics Cannabis
Exposures Cannabis
Q3 Earnings Outperformers: Celsius (NASDAQ:CELH) And The Rest Of The Beverages, Alcohol and Tobacco Stocks
Via StockStory
Topics Cannabis
Exposures Cannabis
Shareholder Lawsuit Challenges Tilray's Voting Tactics For Authorized Share Increase
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Tilray Joins German Cannabis Fiesta With First Locally Grown Strains
Via Benzinga
Topics Cannabis
Exposures Cannabis
CBD Pioneer Charlotte's Web Narrows Loss In Q3, Focuses On Long-Term Growth
Via Benzinga
Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer American Lager and Hosts The Blue Point Blitz Celebration at Webster Hall
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
From Tilray Brands, Inc.
Via GlobeNewswire
Get Ready for Winter with 10 Barrel’s 13th Annual Pray for Snow Party
From Tilray Brands, Inc.
Via GlobeNewswire
Breckenridge Distillery's Latest Creation is the Perfect Addition to Your Holiday Bar: Breckenridge Candy Cane Vodka
From Tilray Brands, Inc.
Via GlobeNewswire
Does the Rejection of Top Marijuana Legalization Measures Doom the Pot Industry?
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
420 with CNW — German Marijuana Club Hands Out Legal Cannabis as Pilot Program Kicks Off
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Experience the Ultimate 420 Festival Celebration with SweetWater's 20th Anniversary Lineup Featuring The Revivalists, Marcus King Band, Greensky Bluegrass, Drive-By Truckers and Cypress Hill at Atlanta's Iconic Pullman Yards from April 18-20, 2025
From Tilray Brands, Inc.
Via GlobeNewswire
Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Extract Significantly Reduces Chemotherapy-Induced Vomiting, Tilray-Backed Study Reveals
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics
From Tilray Brands, Inc.
Via GlobeNewswire
Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
From Tilray Brands, Inc.
Via GlobeNewswire
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.